Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Alnylam Pharmaceuticals Inc.
Director
Rani Therapeutics Holdings Inc.
Director
Seres Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +9,000 | $72.01 | $648,090 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +5,153 | $128.31 | $661,181 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +4,581 | $148.77 | $681,515 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +5,228 | $151.22 | $790,578 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +4,032 | $171.95 | $693,302 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +3,454 | $189.87 | $655,811 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,985 | $430.81 | $855,158 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,938 | $432.94 | $839,038 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −2,098 | $434.50 | $911,581 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −7,675 | $435.40 | $3,341,695 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −5,358 | $436.00 | $2,336,088 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,922 | $437.56 | $840,990 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −2,086 | $438.34 | $914,377 |
| Aug 14, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −5,302 | $439.27 | $2,329,010 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.